Arginine-rich C9ORF72 ALS proteins stall ribosomes in a manner distinct from a canonical ribosome-associated quality control substrate
Journal Title
Journal of Biological Chemistry
Publication Type
epub ahead of print
Abstract
Hexanucleotide expansion mutations in C9ORF72 are a frequent cause of amyotrophic lateral sclerosis. We previously reported that long arginine-rich dipeptide repeats (DPR), mimicking abnormal proteins expressed from the hexanucleotide expansion, caused translation stalling when expressed in cell culture models. Whether this stalling provides a mechanism of pathogenicity remains to be determined. Here we explored the molecular features of DPR-induced stalling and examined whether known mechanisms such as ribosome quality control (RQC) regulate translation elongation on sequences that encode arginine-rich DPRs. We demonstrate that arginine-rich DPRs lead to stalling in a length-dependent manner, with lengths longer than 40 repeats invoking severe translation arrest. Mutational screening of 40×Gly-Xxx DPRs shows that stalling is most pronounced when Xxx is a charged amino acid (Arg, Lys, Glu, or Asp). Through a genome-wide knockout screen, we find that genes regulating stalling on polyadenosine mRNA coding for poly-Lys, a canonical RQC substrate, act differently in the case of arginine-rich DPRs. Indeed, these findings point to a limited scope for natural regulatory responses to resolve the arginine-rich DPR stalls, even though the stalls may be sensed, as evidenced by an upregulation of RQC gene expression. These findings therefore implicate arginine-rich DPR-mediated stalled ribosomes as a source of stress and toxicity and may be a crucial component in pathomechanisms.
Publisher
Elsevier
Keywords
C9orf72 als; RNA-protein interaction; arginine-rich dipeptide repeats; neurodegenerative disease; protein misfolding; ribosome function; ribosome stalling; translation
Research Division(s)
Epigenetics And Development
PubMed ID
36481270/
Open Access at Publisher's Site
https://doi.org/ 10.1016/j.jbc.2022.102774
Terms of Use/Rights Notice
Refer to copyright notice on published article.


Creation Date: 2022-12-13 03:11:33
Last Modified: 2022-12-14 01:19:25
An error has occurred. This application may no longer respond until reloaded. Reload 🗙